Search
Descriptor English: Insulin Detemir
Descriptor Spanish: Insulina Detemir
Descriptor insulina detemir
Scope note: Insulina recombinante de acción prolongada y agente hipoglucemiante en la que un ÁCIDO MIRÍSTICO se conjuga con una LISINA en la posición B29. Se utiliza para controlar la GLUCEMIA en pacientes con DIABETES MELLITUS.
Descriptor Portuguese: Insulina Detemir
Descriptor French: Insuline détémir
Entry term(s): 12C-Lys(B29)-DB30I
B29 tetradecanoyl Lys B30 des Ala insulin
B29-tetradecanoyl-Lys-B30-des-Ala-insulin
Basal Insulin Detemir
Des-(B30)-insulin, Lys(B29)-tetradecanoyl
Detemir, Basal Insulin
Detemir, Insulin
Insulin Detemir, Basal
Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)
Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)
Levemir
NN 304
NN-304
NN304
Tree number(s): D06.472.699.587.200.300.050
D12.644.548.586.200.300.050
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069057
Scope note: A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Hypoglycemic Agents
Registry Number: 4FT78T86XV
Public MeSH Note: 2016; INSULIN DETEMIR was indexed under INSULIN, LONG-ACTING 2011-2015; under INSULIN 1997-2011; and under CARRIER PROTEINS 1997-2004
History Note: 2016 (1997)
DeCS ID: 55955
Unique ID: D000069057
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2017/01/17
Insulin Detemir - Preferred
Concept UI M0274330
Scope note A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
Preferred term Insulin Detemir
Entry term(s) Basal Insulin Detemir
Detemir, Basal Insulin
Detemir, Insulin
Insulin Detemir, Basal
NN304 - Narrower
Concept UI M0274327
Preferred term NN304
Entry term(s) NN 304
NN-304
B29-tetradecanoyl-Lys-B30-des-Ala-insulin - Narrower
Concept UI M000623458
Preferred term B29-tetradecanoyl-Lys-B30-des-Ala-insulin
Entry term(s) 12C-Lys(B29)-DB30I
B29 tetradecanoyl Lys B30 des Ala insulin
Des-(B30)-insulin, Lys(B29)-tetradecanoyl
Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)
Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)
Levemir - Narrower
Concept UI M0454108
Preferred term Levemir



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey